Table 3 Prediction of cardiovascular risk variables and serum 25-hydroxyvitamin D
Variables | R2 | ANOVA | Model | B | β | P-value* |
|---|---|---|---|---|---|---|
Log (25-hydroxyvitamin D (ng/mL)) | 0.26 | F = 4.54, p-value < 0.01 | Constant BMI HDL-C Log (HbA1c) Gender Smoking | 1.55 <− 0.01 0.38 − 0.69 − 0.03 − 0.08 | - −0.05 0.34 − 0.25 − 0.06 − 0.24 | < 0.001 0.69 < 0.01 0.02 0.69 0.09 |
SBP (mmHg) | 0.51 | F = 34.0, p-value < 0.001 | Constant DBP Gender Smoking | 52.16 1.00 −3.31 0.61 | - 0.72 0.72 0.04 | < 0.01 < 0.01 0.16 0.62 |
DBP (mmHg) | 0.55 | F = 30.13, p-value < 0.001 | Constant BMI SBP Gender Smoking | 3.99 0.32 0.49 2.65 − 0.42 | - 0.18 0.69 0.13 − 0.04 | 0.58 0.02 < 0.001 0.10 0.65 |
Log (FBG (mmol/L)) | 0.54 | F = 18.98, p-value < 0.001 | Constant Age Log (HbA1c) Gender Smoking | − 0.10 < 0.01 1.14 0.03 − 0.03 | - 0.07 0.71 0.09 − 0.15 | 0.39 0.47 < 0.001 0.42 0.18 |
Log (HbA1c (%)) | 0.57 | F = 17.48, p-value < 0.001 | Constant Log (FBG) Log (TGs) Log (25-hydroxyvitamin D) Gender Smoking | 0.48 0.42 0.08 − 0.06 − 0.01 0.01 | - 0.67 0.14 − 0.15 − 0.04 − 0.06 | < 0.001 < 0.001 0.09 0.09 0.66 0.59 |
HDL-C (mmol/L) | 0.33 | F = 9.17, p-value < 0.001 | Constant LDL-C Log (TGs) Log (25-hydroxyvitamin D) Gender Smoking | 0.40 0.07 − 0.34 0.21 0.20 0.02 | - 0.24 − 0.24 0.22 0.36 0.07 | 0.01 < 0.01 < 0.01 0.02 < 0.01 0.52 |
LDL-C (mmol/L) | 0.09 | F = 3.15, p-value = 0.03 | Constant HDL-C Gender Smoking | 2.75 0.91 − 0.09 − 0.20 | - 0.26 − 0.05 − 0.19 | < 0.001 0.02 0.72 0.10 |
Log (TGs (mmol/L)) | 0.17 | F = 3.42, p-value = 0.01 | Constant Log (HbA1c) HDL-C Gender Smoking | 0.23 0.41 −0.21 − 0.02 − 0.01 | - 0.23 − 0.28 − 0.04 − 0.02 | 0.26 < 0.05 0.03 0.78 0.86 |
Total Cholesterol | 1.00 | F = 5240.16, p-value < 0.001 | Constant HDL-C LDL-C Log (TGs) Gender Smoking | 0.04 1.05 1.00 1.19 0.01 < 0.001 | - 0.27 0.88 0.22 < 0.01 < 0.001 | 0.25 < 0.001 < 0.001 < 0.001 0.72 0.96 |